ESTUDIO DE LAS ALTERACIONES NEUROLÓGICAS, CEREBRALES Y BIOQUÍMICAS EN PACIENTES CON ENFERMEDAD GRASA DEL HÍGADO. MECANISMOS MOLECULARES Y CELULARES.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
CONSELLERIA EDUCACION/INNOVACION,UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL/EMPLEO
Resultados del Ensayo Clínico
A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease.
Gimenez-Garzo, C; (...); Montoliu, C
Article. 10.3390/jcm10132806. 2021
Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy.
Ballester, Maria-Pilar; (...); Montoliu, Carmina
Article. 10.1038/s41598-022-06416-z. 2022
Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients
Article. 10.3390/ijms241914727. 2023
Patients with Minimal Hepatic Encephalopathy Show Altered Thermal Sensitivity and Autonomic Function.
Rega, Dalia; (...); Montoliu, Carmina
Article. 10.3390/jcm10020239. 2021
Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy.
Gallego, JJ; (...); Montoliu, C
Article. 10.3390/ijms232012335. 2022